Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Maria E. Laucho-Contreras"'
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Externí odkaz:
https://doaj.org/article/2f6bd31344dc4c6c937c44d5c6df1cc4
Autor:
Maria Montes de Oca, Maria Victorina Lopez Varela, Maria E. Laucho-Contreras, Alejandro Casas, Eduardo Schiavi, Juan Carlos Mora
Publikováno v:
BMC Pulmonary Medicine, Vol 17, Iss 1, Pp 1-11 (2017)
Abstract Background Asthma–COPD overlap syndrome (ACOS) prevalence varies depending on the studied population and definition criteria. The prevalence and clinical characteristics of ACOS in an at-risk COPD primary care population from Latin America
Externí odkaz:
https://doaj.org/article/54e9dd8ace9542b09cb842a7bca66980
Autor:
Maria E. Laucho‐Contreras, Francesca Polverino, Joselyn Rojas‐Quintero, Xiaoyun Wang, Caroline A. Owen
Publikováno v:
Physiological Reports, Vol 6, Iss 15, Pp n/a-n/a (2018)
Abstract Low serum CC16 levels are associated with accelerated lung function decline in human population studies, but it is not known whether low serum CC16 levels contribute to lung function decline, or are an epiphenomenon. We tested the hypothesis
Externí odkaz:
https://doaj.org/article/95114f91a38e4112b79dd42815beab38
Publikováno v:
European Respiratory Review, Vol 29, Iss 158 (2020)
The early stages of COPD have recently become a hot topic as many new risk factors have been proposed, but substantial knowledge gaps remain in explaining the natural history of the disease. If we are to modify the outcomes of COPD, early detection n
Autor:
Gustavo Zabert, Filip Surmont, Maria E. Laucho-Contreras, Maria Victorina Lopez Varela, Dolores Moreno, Maria Montes de Oca
Publikováno v:
Respiratory Care. 62:1058-1066
BACKGROUND: The evidence indicates that risk factors other than smoking are important in the development of COPD. It has been postulated that less traditional risk factors (eg, exposure to coal and/or biomass smoke) may interact with smoking to furth
Autor:
Eduardo Schiavi, Alejandro Casas, Maria Montes de Oca, Maria E. Laucho-Contreras, Juan Carlos Mora, Maria Victorina Lopez Varela
Publikováno v:
BMC Pulmonary Medicine, Vol 17, Iss 1, Pp 1-11 (2017)
BMC Pulmonary Medicine
BMC Pulmonary Medicine
Background Asthma–COPD overlap syndrome (ACOS) prevalence varies depending on the studied population and definition criteria. The prevalence and clinical characteristics of ACOS in an at-risk COPD primary care population from Latin America was asse
Autor:
Alejandra Rey, Alejandra Silva, Maria E. Laucho-Contreras, Maria Victorina Lopez Varela, Alejandro Casas, Maria Montes de Oca, Eduardo Schiavi
Publikováno v:
Archivos de Bronconeumología. 53:98-106
Resumen Introduccion En los diferentes sistemas de clasificacion de la EPOC se utilizan diversos criterios de estadificacion. El objetivo de este estudio fue comparar la prevalencia y la distribucion de los estadios de la EPOC con las recomendaciones
Autor:
Alejandra Silva, Alejandra Rey, Eduardo Schiavi, Alejandro Casas, Maria E. Laucho-Contreras, Maria Victorina Lopez Varela, Maria Montes de Oca
Publikováno v:
Archivos de Bronconeumología (English Edition). 53:98-106
Introduction Several classification systems use different criteria when assessing COPD stages. The objective of this study was to compare the prevalence and distribution of COPD stages using Global initiative for chronic Obstructive Lung Disease (GOL
Publikováno v:
Current Pharmaceutical Design. 22:6273-6282
Background: Although some patients with obstructive lung disease (OLD) have features of both asthma and chronic obstructive pulmonary disease (COPD), the term "asthma-COPD overlap syndrome (ACOS)" was coined only relatively recently. However, there a
Autor:
Amanda Iglesias, Maria E. Laucho-Contreras, Andreas Jahn, Lynette M. Sholl, Francesca Polverino, Ángel Ríos, Ivan O. Rosas, Borja G. Cosío, Bartolome R. Celli, Paula Tejera, Caroline A. Owen, Jaime Pons, Jaume Sauleda, Victor Pinto-Plata, Alvar Agusti, Miguel Divo
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 192:695-705
Rationale: Patients with chronic obstructive pulmonary disease (COPD) have increased pulmonary lymphoid follicle (LF) counts. B cell–activating factor of tumor necrosis factor family (BAFF) regulates B cells in health, but its role in COPD pathogen